Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
about
Sublingual immunotherapy for treating allergic conjunctivitisAllergen injection immunotherapy for seasonal allergic rhinitisHow does the efficacy and safety of Oralair(®) compare to other products on the market?Critical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis.Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patientsTherapeutic interventions in severe asthmaDifferential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response.A survey of clinical features of allergic rhinitis in adults.Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy.Treatment of grass pollen allergy: focus on a standardized grass allergen extract - Grazax®.Allergen-specific immunotherapy.Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoBudget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitisAllergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analysesAn accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial.Role of skin prick test in allergic disorders: a prospective study in kashmiri population in light of review.Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.Allergen immunotherapy for allergic respiratory diseasesThe efficacy assessment of a self-administered immunotherapy protocolPerennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitisARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review.5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study.Diagnosis and management of chronic rhinosinusitis in adults.Antigen-specific immunotherapy of autoimmune and allergic diseasesEmerging sublingual immunotherapy drugs.Clinical immunology review series: an approach to desensitization.How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.Mechanisms of immunotherapy to aeroallergens.One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions.A comparison of immunotherapy delivery methods for allergen immunotherapy.Immunotherapy preparation guidelines, rules, and regulation.Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.Pharmacotherapy of allergic rhinitis: current options and future perspectives.Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.Updating the role played by immunotherapy for allergic rhinitis: meta-analysis.Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.Local IgE in non-allergic rhinitis.
P2860
Q24235657-C2891241-8CBB-422F-9E93-535E4899C4CDQ24243115-F0BBC67B-24E5-4967-9D98-A3A628D6A91DQ26745596-4466E7BD-D958-4D8A-A9AE-1910333DC2E6Q26775905-FA3A4989-2F90-4B87-B139-9375F9908450Q27700098-9B042248-6BA0-40CF-84D9-F7439DBC845EQ28079238-80F9269F-5ECE-4049-8424-22EB616A96A3Q30402227-328754F5-C732-48CE-ACD3-B301BCF6738DQ34496568-A1635225-7744-43EC-8DEF-BF276F16A054Q34580968-BFD1D22D-510B-4825-8415-544DFF22F4CFQ34606056-7ECA0E1F-EA86-4485-9F75-A5B7E3D2494FQ35632139-0622655B-FF43-42DE-954B-98B3EF83AC13Q35777126-D902CF9F-5D7A-489F-BB41-B1D30412693CQ36407474-CDAFE775-E6E8-41BE-AF1B-3630DCB88801Q36411170-03AC7BD9-141B-499A-8415-AE3AAEBBC202Q36529630-4452D913-BF00-4F7E-BF84-A1279986BF28Q36563436-9D1E3C81-DE2B-4F92-BE29-FCE39647124CQ36826600-E14A88B7-FEA0-466E-AD15-6805456AB75AQ36864947-9C55A8B9-7E89-4F51-9A79-73EAC8C3E695Q36881918-FF0C8346-528C-4B27-AD64-6E9CF8E77912Q37013813-9DD0E09D-1397-4F69-81B8-A562826724A9Q37150461-15AE9366-CF3A-45DE-B37A-3E92DAD95B4AQ37390510-4C618A22-E4D7-41B3-B58F-D12560808C29Q37638988-12AA0CBD-6D26-4F1C-8BCD-112D2C664762Q37790023-F6A409A2-1115-4A80-A416-E38AEDA0A7E1Q37801372-959E6524-E127-4CBE-87F3-B9461ADCB4B3Q37822834-3290316E-F562-42AF-90BA-AFBFD9AD9DCCQ37865584-09EC5FF8-E4BF-4115-83CF-00277C332049Q37888684-B2221A43-5E73-4E5E-B9A2-E3BF58647B92Q37901536-D9875A33-DF4E-42DB-8A13-96AF08351524Q37981739-4A3013B8-9865-4C5D-86B9-92E54EEDF803Q38103286-A40C93F6-2B49-4E6D-ABC0-7C68018ED73AQ38110730-0B0C6B9D-ED6A-4EDB-BC01-3D871E40E374Q38119883-1DE55816-6F83-46A3-A6A3-DC6C5202685CQ38161991-D83F2433-FB4E-456B-8E34-C7F81ED4DEC0Q38180216-66F1179F-32FA-4B50-84CD-4EA8EAFB9A78Q38206795-ADE62936-2020-4995-A487-D0066ABB7CDEQ38262168-294AE864-4634-4BFB-9085-82EADAE68484Q38271427-A0C38B1A-BBD2-4D70-A41D-6C9BFB57FBCFQ38284820-149728BC-A0D2-4F57-B8FB-1D582A9E6981Q38286280-2D2D3207-A9A2-48E3-8CA5-188E8C4CB4F9
P2860
Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Efficacy and safety of specifi ...... allergic rhinoconjunctivitis.
@en
type
label
Efficacy and safety of specifi ...... allergic rhinoconjunctivitis.
@en
prefLabel
Efficacy and safety of specifi ...... allergic rhinoconjunctivitis.
@en
P2093
P1476
Efficacy and safety of specifi ...... allergic rhinoconjunctivitis.
@en
P2093
Anthony J Frew
Christopher J Corrigan
Richard J Powell
Stephen R Durham
UK Immunotherapy Study Group
P304
P356
10.1016/J.JACI.2005.11.014
P407
P577
2006-02-01T00:00:00Z